Risperidone for system suitability
SIAL/Y0000370 - European Pharmacopoeia (EP) Reference Standard
Synonym: Risperidone; R 64,766
CAS Number: 106266-06-2
Empirical Formula (Hill Notation): C23H27FN4O2
Molecular Weight: 410.48
MDL Number: MFCD00274576
Linear Formula: C23H27FN4O2
Product Type: Chemical
API family | risperidone |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C23H27FN4O2/c1-15-18(2 |
InChI key | RAPZEAPATHNIPO-UHFFFAOYSA |
manufacturer/tradename | EDQM |
SMILES string | CC1=C(CCN2CCC(CC2)c3noc4c |
Application: | Risperidone for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia. |
General description: | Risperidone is a new central 5-hydroxytryptamine2 and dopamine D2 antagonist. It is used to treat agitation, aggression,and psychosis caused during demnetia. It is a neuroleptic drug. It is also an atypical antipsychotic drug which is used for treating schizophrenia. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Packaging: | The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
Symbol | GHS06 |
Signal word | Danger |
Hazard statements | H301 |
Precautionary statements | P301 + P330 + P331 + P310 |
RIDADR | UN 2811 6.1 / PGIII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
UNSPSC | 41116107 |